{
  "id": "IMDC_risk_model_metastiatic_renal_cell_carcinoma.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-08-17",
      "name": "Therese Lindberg",
      "organisation": "Cambio CDS",
      "email": "therese.lindberg@cambio.se"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict survival in patients with metastatic renal cell carcinoma treated with systemic therapy. ",
        "keywords": [
          "IMDC",
          "calcium",
          "platelets",
          "hemoglobin",
          "metastatic renal cell carcinoma"
        ],
        "use": "The IMDC Risk Score is calculated from the following parameters: \n\n<1 year from time of diagnosis to systemic therapy, Karnofsky performance status <80%, Hemoglobin < lower limit of normal (usually ~120 g/L or 12 g/dL), Corrected calcium > upper limit of normal (usually ~8.5-10.2 mg/dL), Neutrophils > upper limit of normal (usually ~2.0-7.0×10⁹/L) and Platelets > upper limit of normal (usually ~150,000-400,000 cells/µL).  \n\nInterpretation:\nIMDC Risk Score     Risk group       Median survival\n0                               Favorable          43.2 months\n1-2                           Intermediate      22.5 months\n≥3                            Poor                   7.8 months",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study. JCO Dec 1, 2009:5794-5799; published online on October 13, 2009."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "template_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.4]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.12]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.14]/items[at0078.15]"
          }
        }
      },
      "gt0006": {
        "id": "gt0006",
        "model_id": "openEHR-EHR-OBSERVATION.karnofsky_performance_status_scale.v1",
        "template_id": "openEHR-EHR-OBSERVATION.karnofsky_performance_status_scale.v1",
        "type": "INPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          }
        }
      },
      "gt0008": {
        "id": "gt0008",
        "model_id": "openEHR-EHR-EVALUATION.imdc_risk_model_metastatic_renal_cell_carcinoma.v0",
        "template_id": "openEHR-EHR-EVALUATION.imdc_risk_model_metastatic_renal_cell_carcinoma.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/items[at0003]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/items[at0021]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/items[at0025]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/items[at0020]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/items[at0004]"
          },
          "gt0016": {
            "id": "gt0016",
            "path": "/data[at0001]/items[at0006]"
          },
          "gt0026": {
            "id": "gt0026",
            "path": "/data[at0001]/items[at0007]"
          }
        }
      },
      "gt0020": {
        "id": "gt0020",
        "model_id": "openEHR-EHR-EVALUATION.imdc_risk_model_metastatic_renal_cell_carcinoma.v0",
        "template_id": "openEHR-EHR-EVALUATION.imdc_risk_model_metastatic_renal_cell_carcinoma.v0",
        "type": "INPUT",
        "elements": {
          "gt0023": {
            "id": "gt0023",
            "path": "/data[at0001]/items[at0002]"
          },
          "gt0024": {
            "id": "gt0024",
            "path": "/data[at0001]/items[at0005]"
          }
        }
      }
    },
    "default_actions": [
      "$gt0010|Karnofsky Performance Status <80%|=0|local::at0010|No +0|",
      "$gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL|=0|local::at0012|No +0|",
      "$gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L|=0|local::at0016|No +0|",
      "$gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL|=0|local::at0018|No +0|"
    ],
    "rules": {
      "gt0018": {
        "id": "gt0018",
        "priority": 8,
        "when": [
          "$gt0007|Karnofsky score|<80"
        ],
        "then": [
          "$gt0010|Karnofsky Performance Status <80%|=1|local::at0011|Yes +1|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 7,
        "when": [
          "($gt0003|Haemoglobin|<120,gm/l)||($gt0003|Haemoglobin|<12,gm/dl)"
        ],
        "then": [
          "$gt0014|Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL|=1|local::at0013|Yes +1|"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 6,
        "when": [
          "$gt0005|Neutrophils|>7,10*9/l"
        ],
        "then": [
          "$gt0016|Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L|=1|local::at0017|Yes +1|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 5,
        "when": [
          "$gt0004|Platelet count, cells/µL|>400000,cells/uL",
          "$gt0004|Platelet count, cells/µL|.unit=='cells/uL'"
        ],
        "then": [
          "$gt0026|Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL|=1|local::at0019|Yes +1|"
        ]
      },
      "gt0025": {
        "id": "gt0025",
        "priority": 4,
        "when": [
          "$gt0003|Haemoglobin|!=null",
          "$gt0004|Platelet count, cells/µL|!=null",
          "$gt0005|Neutrophils|!=null",
          "$gt0023|<1 year from time of diagnosis to systemic therapy|!=null",
          "$gt0024|Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL|!=null",
          "$gt0007|Karnofsky score|!=null"
        ],
        "then": [
          "$gt0013|IMDC Risk Score|.magnitude=$gt0026.value+$gt0023.value+$gt0024.value+$gt0016.value+$gt0014.value+$gt0010.value"
        ]
      },
      "gt0027": {
        "id": "gt0027",
        "priority": 3,
        "when": [
          "$gt0013|IMDC Risk Score|>=3"
        ],
        "then": [
          "$gt0012|Risk Group|=local::at0028|Poor|",
          "$gt0011|Median survival|=local::at0024|7.8 months|"
        ]
      },
      "gt0028": {
        "id": "gt0028",
        "priority": 2,
        "when": [
          "$gt0013|IMDC Risk Score|>0",
          "$gt0013|IMDC Risk Score|<3"
        ],
        "then": [
          "$gt0012|Risk Group|=local::at0027|Intermediate|",
          "$gt0011|Median survival|=local::at0023|22.5 months|"
        ]
      },
      "gt0029": {
        "id": "gt0029",
        "priority": 1,
        "when": [
          "$gt0013|IMDC Risk Score|==0"
        ],
        "then": [
          "$gt0012|Risk Group|=local::at0026|Favorable|",
          "$gt0011|Median survival|=local::at0022|43.2 months|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "IMDC_risk_model_metastiatic_renal_cell_carcinoma",
            "description": "IMDC (International Metastatic RCC Database Consortium) Risk Model for Metastatic Renal Cell Carcinoma predicts survival in patients with metastatic renal cell carcinoma treated with systemic therapy (also known as Heng criteria)."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Haemoglobin",
            "description": "The mass concentration of haemoglobin"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Platelet count, cells/µL",
            "description": "The number of platelets per litre"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Neutrophils",
            "description": "The number of neutrophils per litre"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Karnofsky score",
            "description": "Final score"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Karnofsky Performance Status <80%",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Median survival",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Risk Group",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "IMDC Risk Score",
            "description": "*"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Hemoglobin < lower limit of normal. Usually ~120 g/L or 12 g/dL",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Neutrophils > upper limit of normal. Usually ~2.0-7.0×10⁹/L",
            "description": "*"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Karnofsky Performance Status <80%"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Hemoglobin < lower limit of normal"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Neutrophils > upper limit of normal"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Platelets > upper limit of normal"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "<1 year from time of diagnosis to systemic therapy",
            "description": "*"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "Corrected calcium > upper limit of normal. Usually ~8.5-10.2 mg/dL",
            "description": "*"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Caluclate IMDC Risk Score"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Platelets > upper limit of normal. Usually ~150,000-400,000 cells/µL",
            "description": "*"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Risk Group: Poor"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Risk Group: Intermediate"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "Risk Group: Favorable"
          }
        }
      }
    }
  }
}